[20220218]IF12051_新冠病毒-19：前进的道路.pdf

https:/crsreports.congress.gov February 18, 2022COVID-19: The Way ForwardIntroduction The Coronavirus Disease 2019 (COVID-19) pandemic is in its third year. The number of new cases from the Omicron variant appears to be ebbing, but the daily death toll remains high. Domestically, a weary public hopes for a full return to economic and civic life. Many low- and middle-income countries have limited access to COVID-19 vaccines, therapeutics, personal protective equipment (PPE), and other countermeasures. Some of these countries have correspondingly low vaccination rates, when compared to high-income countries. At this stage of the pandemic, it remains unclear when the crisis period, including factors such as level of strain on health systems, health workers and daily death tolls, will end. Questions remain about whether new variants will emerge and whether they will be more or less lethal than the currently dominant Omicron variant. This In Focus accompanies the CRS Issues and Policy Seminar “COVID-19: The Way Forward,” in which CRS analysts and attorneys present on various aspects of U.S. government domestic and global pandemic responses and congressional actions and options. The U.S